Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer’s disease

PURPOSE: In order to maximise the utility of [(11)C]-PBR28 for use in longitudinal studies and clinical trials in Alzheimer’s disease (AD), there is a need to develop non-invasive metrics of tracer binding that do not require arterial cannulation. Recent work has suggested that standardised uptake v...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Akshay, Veronese, Mattia, Xu, Xiaohui, Curtis, Charles, Turkheimer, Federico, Howard, Robert, Reeves, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039146/
https://www.ncbi.nlm.nih.gov/pubmed/27678494
http://dx.doi.org/10.1186/s13550-016-0226-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039146/
https://www.ncbi.nlm.nih.gov/pubmed/27678494
http://dx.doi.org/10.1186/s13550-016-0226-3

Ejemplares similares